Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture

Journal of Lipid Research

Volumn 54, Issue 12, 2013, Pages 3303-3311

  Hawkins Salsbury, Jacqueline A ^a   Parameswar, Archana R ^c   Jiang, Xuntian ^a   Schlesinger, Paul H ^b   Bongarzone, Ernesto ^d   Ory, Daniel S ^a   Demchenko, Alexei V ^c   Sands, Mark S ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Enantiomer; Krabbe disease; Membrane alteration

Indexed keywords

PROTEIN KINASE C; PSYCHOSINE;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; ENANTIOMER; GLOBOID CELL LEUKODYSTROPHY; HUMAN; HUMAN CELL; LIPID RAFT; LIPOGENESIS; MEMBRANE DAMAGE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION;

ENANTIOMER; KRABBE DISEASE; MEMBRANE ALTERATION;

ANIMALS; APOPTOSIS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CYTOTOXINS; HUMANS; LEUKODYSTROPHY, GLOBOID CELL; LIPOSOMES; PROTEIN KINASE C; PROTEIN TRANSPORT; PSYCHOSINE; STEREOISOMERISM;

EID: 84887977925     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M039610     Document Type: Article

References (38)

1. Wenger, D., K. Suzuki, and Y. Suzuki. 2001. Galactosylceramide Lipidosis: Globoid Cell Leukodystrophy (Krabbe Disease). In The Metabolic & Molecular Basis of Disease. C. Scriver, A. Beaudet, W. Sly, D. Valle, B. Childs, K. Kinzler, and B. Vogelstein, editors. McGraw-Hill Medical Publishing Division, New York. 2669-3694.
2. Castelvetri, L. C., M. I. Givogri, H. Zhu, B. Smith, A. Lopez-Rosas, X. Qiu, R. Van Breemen, and E. R. Bongarzone. 2011. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 122:35-48.
3. Wenger, D. A., M. Sattler, and W. Hiatt. 1974. Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase. Proc. Natl. Acad. Sci. USA. 71:854-857.
4. Svennerholm, L., M. T. Vanier, and J. E. Mansson. 1980. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J. Lipid Res. 21:53-64. (Pubitemid 10120438)
5. Nagara, H., H. Ogawa, Y. Sato, T. Kobayashi, and K. Suzuki. 1986. The twitcher mouse: degeneration of oligodendrocytes in vitro. Brain Res. 391:79-84. (Pubitemid 16168197)
6. Miyatake, T., and K. Suzuki. 1973. Additional deficiency of psychosine galactosidase in globoid cell leukodystrophy: an implication to enzyme replacement therapy. Birth Defects Orig. Artic. Ser. 9:136-140.
7. Vanier, M., and L. Svennerholm. 1976. Chemical pathology of Krabbe disease: the occurrence of psychosine and other neutral sphingoglycolipids. Adv. Exp. Med. Biol. 68:115-126.
8. Suzuki, K. 1998. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem. Res. 23:251-259.
9. Yamada, H., and K. Suzuki. 1999. Responses to cyclic AMP is impaired in the twitcher Schwann cells in vitro. Brain Res. 816:390-395. (Pubitemid 29225386)
10. Haq, E., S. Giri, I. Singh, and A. K. Singh. 2003. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J. Neurochem. 86:1428-1440. (Pubitemid 37174259)
11. Khan, M., E. Haq, S. Giri, I. Singh, and A. K. Singh. 2005. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J. Neurosci. Res. 80:845-854. (Pubitemid 40961296)
12. Contreras, M. A., E. Haq, T. Uto, I. Singh, and A. K. Singh. 2008. Psychosine-induced alterations in peroxisomes of twitcher mouse liver. Arch. Biochem. Biophys. 477:211-218.
13. Giri, S., M. Khan, N. Nath, I. Singh, and A. K. Singh. 2008. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J. Neurochem. 105:1820-1833. (Pubitemid 351678503)
14. White, A. B., M. I. Givogri, A. Lopez-Rosas, H. Cao, R. Van Breemen, G. Thinakaran, and E. R. Bongarzone. 2009. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture. J. Neurosci. 29:6068-6077.
15. Leventis, R., and J. R. Silvius. 2001. Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys. J. 81:2257-2267. (Pubitemid 32917174)
16. Yang, X., S. Askarova, and J. C. Lee. 2010. Membrane biophysics and mechanics in Alzheimer's disease. Mol. Neurobiol. 41:138-148.
17. Hendrich, A. B., and K. Michalak. 2003. Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr. Drug Targets. 4:23-30. (Pubitemid 36131638)
18. Waczuliková, I., M. Cagalinec, O. Ulicna, P. Slezak, and A. Ziegelhoffer. 2010. Biophysical investigation on left ventricular myocytes in rats with experimentally induced diabetes. Physiol. Res. 59(Suppl 1):S9-S17.
19. Covey, D. F. 2009. ent-Steroids: novel tools for studies of signaling pathways. Steroids. 74:577-585.
20. Langmade, S. J., S. E. Gale, A. Frolov, I. Mohri, K. Suzuki, S. H. Mellon, S. U. Walkley, D. F. Covey, J. E. Schaffer, and D. S. Ory. 2006. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc. Natl. Acad. Sci. USA. 103:13807-13812. (Pubitemid 44413989)
21. Gale, S. E., E. J. Westover, N. Dudley, K. Krishnan, S. Merlin, D. E. Scherrer, X. Han, X. Zhai, H. L. Brockman, R. E. Brown, et al. 2009. Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions. J. Biol. Chem. 284:1755-1764.
22. Bielska, A. A., P. Schlesinger, D. F. Covey, and D. S. Ory. 2012. Oxysterols as non-genomic regulators of cholesterol homeostasis. Trends Endocrinol. Metab. 23:99-106.
23. Parameswar, A. R., and J. A. Hawkins, Mydock, L. K., Sands, M. S., Demchenko, A. V. 2010. Consise synthesis of the unnatural sphingosine and psychosine enantiomer. Eur. J. Org. Chem. 3269-3274.
24. Szoka, F., Jr., and D. Papahadjopoulos. 1978. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA. 75:4194-4198. (Pubitemid 9025976)
25. Galbiati, F., V. Basso, L. Cantuti, M. I. Givogri, A. Lopez-Rosas, N. Perez, C. Vasu, H. Cao, R. Van Breemen, A. Mondino, et al. 2007. Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease. J. Neurosci. 27:13730-13738. (Pubitemid 350278274)
26. Whitfield, P. D., P. C. Sharp, R. Taylor, and P. Meikle. 2001. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry. J. Lipid Res. 42:2092-2095. (Pubitemid 34001059)
27. Jatana, M., S. Giri, and A. K. Singh. 2002. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci. Lett. 330:183-187. (Pubitemid 35257895)
28. Zaka, M., and D. A. Wenger. 2004. Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation. Neurosci. Lett. 358:205-209. (Pubitemid 38368205)
29. Dekker, L. V. 2004. Protein Kinase C. 2nd ed. Landes Bioscience/Eurekah. com United States, Georgetown, TX.
30. Pajewski, R., N. Djedovic, E. Harder, R. Ferdani, P. H. Schlesinger, and G. W. Gokel. 2005. Pore formation in and enlargement of phospholipid liposomes by synthetic models of ceramides and sphingomyelin. Bioorg. Med. Chem. 13:29-37. (Pubitemid 39575689)
31. Lange, Y., J. Ye, M. E. Duban, and T. L. Steck. 2009. Activation of membrane cholesterol by 63 amphipaths. Biochemistry. 48:8505-8515.
32. Igisu, H., N. Hamasaki, A. Ito, and W. Ou. 1988. Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. Lipids. 23:345-348.
33. Igisu, H., and M. Nakamura. 1986. Inhibition of cytochrome c oxidase by psychosine (galactosylsphingosine). Biochem. Biophys. Res. Commun. 137:323-327. (Pubitemid 16056069)
34. Cooper, C. E., M. Markus, S. P. Seetulsingh, and J. M. Wrigglesworth. 1993. Kinetics of inhibition of purified and mitochondrial cytochrome c oxidase by psychosine (beta-galactosylsphingosine). Biochem. J. 290:139-144. (Pubitemid 23081211)
35. Wang, X. Q., Q. Yan, P. Sun, J. W. Liu, L. Go, S. M. McDaniel, and A. S. Paller. 2007. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res. 67:9986-9995. (Pubitemid 47621249)
36. Nachtergaele, S., L. K. Mydock, K. Krishnan, J. Rammohan, P. H. Schlesinger, D. F. Covey, and R. Rohatgi. 2012. Oxysterols are allosteric activators of the oncoprotein Smoothened. Nat. Chem. Biol. 8:211-220.
37. Liu, B., C. M. Ramirez, A. M. Miller, J. J. Repa, S. D. Turley, and J. M. Dietschy. 2010. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J. Lipid Res. 51:933-944.
38. Ramirez, C. M., B. Liu, A. M. Taylor, J. J. Repa, D. K. Burns, A. G. Weinberg, S. D. Turley, and J. M. Dietschy. 2010. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr. Res. 68:309-315.